Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.4K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

353
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
353
Pneumonia IV: Management01:28

Pneumonia IV: Management

424
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
424
Vaccinations01:51

Vaccinations

45.2K
Overview
45.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

425
The pathophysiology of pneumonia involves the following steps:
425
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

301
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
301

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lower plasma resolvin D1 level and greater sputum eosinophilia characterize a cluster of severe asthma patients.

Respiratory research·2026
Same author

Polyunsaturated fatty acids modulation of smoking-related epigenetics and pulmonary outcomes.

Genes & nutrition·2026
Same author

Lesion network localization of depression in multiple sclerosis.

Nature. Mental health·2026
Same author

Sustained Reduction in Cardiopulmonary Fitness in Long COVID: A Report from the RECOVER-adult Cohort Study.

JACC. Advances·2026
Same author

Current modeling approaches for drug delivery to the central nervous system.

Therapeutic delivery·2026
Same author

The Unusual Suspects.

The New England journal of medicine·2026

Related Experiment Video

Updated: Aug 21, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K

COVID-19 Vaccination reduced pneumonia severity.

Noriaki Wada1, Yi Li2, Takuya Hino3

  • 1Center for Pulmonary Functional Imaging, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

European Journal of Radiology Open
|November 17, 2022
PubMed
Summary

COVID-19 vaccination and boosters significantly reduce the severity of COVID-19 pneumonia on CT scans. Vaccinated individuals, including those with boosters, showed milder pneumonia compared to unvaccinated individuals during the Delta and Omicron variants periods.

Keywords:
COVID-19COVID-19, coronavirus disease 2019CTDAD, diffuse alveolar damageGGO, ground-glass opacityLungOP, organizing pneumoniaPneumoniaRT-PCR, reverse transcription-polymerase chain reactionSARS-CoV-2, severe acute respiratory syndrome coronavirus 2VaccinationmRNA, messenger ribonucleic acid

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.6K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K

Related Experiment Videos

Last Updated: Aug 21, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.6K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K

Area of Science:

  • Radiology
  • Infectious Diseases
  • Immunology

Background:

  • COVID-19 pneumonia presents a significant public health challenge.
  • The Delta and Omicron variants have demonstrated distinct epidemiological characteristics.
  • Understanding the impact of vaccination on disease severity is crucial for public health strategies.

Purpose of the Study:

  • To evaluate the effect of COVID-19 vaccination and booster doses on the severity of COVID-19 pneumonia as assessed by CT scans.
  • To compare radiological findings in vaccinated versus unvaccinated patients during the Delta and Omicron variant surges.

Main Methods:

  • A retrospective study of 303 patients diagnosed with COVID-19 between July 2021 and February 2022.
  • Pneumonia severity was quantified using a 6-point Pneumonia Score on CT scans obtained within 6 weeks of diagnosis.
  • Analysis included demographic data, clinical information, and vaccination status (unvaccinated, fully vaccinated, boosted/additionally vaccinated).

Main Results:

  • A high interobserver agreement (weighted kappa score = 0.875) was achieved for the Pneumonia Score.
  • Patients receiving booster/additional vaccinations were older and had more comorbidities.
  • Significantly lower Pneumonia Scores were observed in boosted (median 2) and fully vaccinated (median 3) groups compared to unvaccinated individuals (median 4).

Conclusions:

  • COVID-19 vaccination, with or without boosters, is associated with reduced severity of COVID-19 pneumonia on CT scans.
  • Radiological evidence supports the protective efficacy of COVID-19 vaccines against severe pneumonia during the Delta and Omicron variant periods.